Senior Pharmacovigilance Specialist
European Medicines Agency
Amsterdam, Noord-Holland, United States
Thomas Goedecke is PRAC Impact Strategy Lead in the Pharmacovigilance Office at EMA. Since joining EMA in 2006, Thomas Goedecke has worked in all areas of pharmacovigilance, including data collection and management in EudraVigilance, signal detection and risk management activities for centrally authorised medicines. Since 2015 he leads on the implementation of the PRAC strategy for measuring impact of pharmacovigilance activities and coordinates the commissioning of impact research and risk minimisation effectiveness studies for the EU regulatory network. He contributes to regulatory and scientific guidance for stakeholders in the area of impact research such as the ENCePP Methods Guide and relevant good pharmacovigilance practice (GVP) guidelines. Other responsibilities include the EU regulatory network’s good practice guide on medication errors.
Disclosure information not submitted.